1. Australian Department of Health and Aging. Schedule of Pharmaceutical Benefits. 2005.
2. Food and Drug Administration. FDA Public Health Advisory: Safety of Vioxx www.fda.gov/cder/drug/infopage/vioxx/PHA_vioxx.htm. 2004.
3. National Institute for Clinical Excellence. Guidance on the use of cyclo-oxygenase (Cox) II selective inhibitors, celecoxib, rofecoxib, meloxicam and etodolac for osteoarthritis and rheumatoid arthritis www.nice.org.uk/pdf/coxiifullguidance.pdf. 2001.
4. National Prescribing Service. NPS News 18 www.nps.org.au/site.php?content=/html/news.php&news=/resources/NPS_News/news18. 2001.